Total Funding
91
73
Total FundingSeed raised
Growth Score 91 in past quarter
-2 pts
Heat Score 73 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
11036
Infinitopes is developer of vaccines for the treatment of cancer.
- Joanna Brewer: Chief Scientific Officer and Interim Chief Operating OfficerPast Role: Adaptimmune, Chief Scientific Officer
- Marcus Harrison: Interim COO
About the Company
Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinical
trials, allowing patients to prevent cancer and tumors from taking their lives